1-6 of 6
Henk J. Bilo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A randomized controlled trial

Susan J. Logtenberg, MD, PHD, Nanne Kleefstra, MD, Sebastiaan T. Houweling, MD, PHD, Klaas H. Groenier, PHD, Reinold O. Gans, MD, PHD, Henk J. Bilo, MD, PHD, FRCP
Journal: Diabetes Care
Diabetes Care 2010;33(6):1169–1172
https://doi.org/10.2337/dc09-1758
Published: 25 February 2010
View article titled, Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: <subtitle>A randomized controlled trial</subtitle>
Open the PDF for Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: <subtitle>A randomized controlled trial</subtitle> in another window
Includes: Supplementary data
Journal Articles

Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial

Susan J. Logtenberg, MD, Nanne Kleefstra, MD, Sebastiaan T. Houweling, MD, PHD, Klaas H. Groenier, PHD, Reinold O. Gans, MD, PHD, Evert van Ballegooie, Henk J. Bilo, MD, PHD, FRCP
Journal: Diabetes Care
Diabetes Care 2009;32(8):1372–1377
https://doi.org/10.2337/dc08-2340
Published: 08 May 2009
View article titled, Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: <subtitle>A randomized controlled trial</subtitle>
Open the PDF for Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: <subtitle>A randomized controlled trial</subtitle> in another window
Includes: Supplementary data
Journal Articles

Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients: Response to Stettler et al.

Roger K. Schindhelm, MD, PHD, MEPI, Michaela Diamant, MD, PHD, Henk J. Bilo, MD, PHD, FRCP, Robbert J. Slingerland, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(11):e89
https://doi.org/10.2337/dc08-1399
Published: 01 November 2008
View article titled, Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients: <subtitle>Response to Stettler et al.</subtitle>
Open the PDF for Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients: <subtitle>Response to Stettler et al.</subtitle> in another window
Journal Articles

Skin Autofluorescence: A tool to identify type 2 diabetic patients at risk for developing microvascular complications

Esther G. Gerrits, MD, Helen L. Lutgers, MD, Nanne Kleefstra, MD, Reindert Graaff, MSC, PHD, Klaas H. Groenier, PHD, Andries J. Smit, MD, PHD, Rijk O. Gans, MD, PHD, Henk J. Bilo, MD, PHD, FRCP
Journal: Diabetes Care
Diabetes Care 2008;31(3):517–521
https://doi.org/10.2337/dc07-1755
Published: 01 March 2008
View article titled, Skin Autofluorescence: <subtitle>A tool to identify type 2 diabetic patients at risk for developing microvascular complications</subtitle>
Open the PDF for Skin Autofluorescence: <subtitle>A tool to identify type 2 diabetic patients at risk for developing microvascular complications</subtitle> in another window
Journal Articles

Skin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 Diabetes

Helen L. Lutgers, MD, Reindert Graaff, MSC, PHD, Thera P. Links, MD, PHD, Lielith J. Ubink-Veltmaat, MD, PHD, Henk J. Bilo, MD, PHD, Rijk O. Gans, MD, PHD, Andries J. Smit, MD, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(12):2654–2659
https://doi.org/10.2337/dc05-2173
Published: 01 December 2006
View article titled, Skin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 Diabetes
Open the PDF for Skin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 Diabetes in another window
Journal Articles

Absorption Kinetics and Action Profiles After Sequential Subcutaneous Administration of Human Soluble and Lente Insulin Through one Needle

Henk J Bilo, MD, Robert J Heine, MD, Anneke C Sikkenk, MD, Jan van der Meer, MD, ED A van der Veen, MD
Journal: Diabetes Care
Diabetes Care 1987;10(4):466–469
https://doi.org/10.2337/diacare.10.4.466
Published: 01 July 1987
View article titled, Absorption Kinetics and Action Profiles After Sequential Subcutaneous Administration of Human Soluble and Lente Insulin Through one Needle
Open the PDF for Absorption Kinetics and Action Profiles After Sequential Subcutaneous Administration of Human Soluble and Lente Insulin Through one Needle in another window